Department Of Pharmaceutical Sciences and Natural Products
Permanent URI for this communityhttps://kr.cup.edu.in/handle/32116/52
Browse
2 results
Search Results
Item Cucumis melo Var. agrestis Naudin as a potent antidiabetic: Investigation via experimental methods(Elsevier B.V., 2022-09-06T00:00:00) Yadav, Jagat Pal; Singh, Ankit Kumar; Grishina, Maria; Pathak, Prateek; Patel, Dinesh KumarBackground: The present study reveals that the ethanolic extract of Cucumis melo var. agrestis (CMVA), can influence the activity of blood glucose level, insulin level, oxidative stress, and lipid profile in Alloxan monohydrate induced diabetic rats. Methods: Wistar albino rats were randomly divided into five groups (n=6), viz. Normal control (non-diabetic), diabetic control (alloxan induced), diabetic treated group (infused with doses 250 and 500 mg/kg b.w) of CMVA ethanolic extract, and standard treated diabetes (infused with pioglitazone 1 mg/kg b.w). Diabetes was induced by administration of alloxan monohydrate (150 mg/kg i.p). The ethanolic extract of CMVA was supplemented orally in different doses for 45 days. Biochemical investigations as well as histopathological examination were carried out accordingly. Results: The diabetic rats supplemented with CMVA significantly decreased blood glucose levels in a dose dependent manner (#p < 0.001). The plasma insulin level was found significantly increased in rats treated with CMVA. However, in CMVA treated group, the oxidative stress parameters (such as SOD, CAT, GSHpx and GSH) and lipid parameters were restored up to normal level (#p < 0.001). Histopathological studies showed that the microscopic architecture of pancreatic cells were improved in CMVA treated groups. Conclusion: The research illustrated that CMVA has potent antidiabetic as well as antioxidant activity along with hypolipidemic effect. Therefore, active phyto-compounds of the selected plants can be isolated and further formulation can be develop in near future. � 2022Item Synthesis, biological evaluation and in-silico ADME studies of novel series of thiazolidin-2,4-dione derivatives as antimicrobial, antioxidant and anticancer agents(BioMed Central Ltd, 2022-09-15T00:00:00) Kumar, Harsh; Kumar, Davinder; Kumar, Pradeep; Thareja, Suresh; Marwaha, Minakshi Gupta; Navik, Umashanker; Marwaha, Rakesh KumarBackground: A novel series of thiazolidine-2,4-dione molecules was derived and their chemical structures were established using physiochemical parameters and spectral techniques (1H-NMR, IR, MS etc.). The synthesized molecule were then evaluated for their antioxidant, anticancer and antimicrobial potential. Results and discussion: Serial tube dilution method was employed to evaluate the antimicrobial potential against selected fungal and bacterial strains by taking fluconazole and cefadroxil as reference antifungal and antibacterial drugs respectively. 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging activity was used to assess the antioxidant potential of the synthesized analogues. Further, the anticancer potential of the selected molecules was assessed against DU-145 cancer cell lines using MTT assay. The drug-likeness was also evaluated by studying in-silico ADME parameters of the synthesized analogues. Conclusion: In antioxidant evaluation studies, the analogue H5 with IC50 = 14.85�?g/mL was found to be the most active molecule. The antimicrobial evaluation outcomes suggested that the molecules H5, H13, H15 and H18 possessed moderate to promising activity against the selected species of microbial strains having MIC range 7.3��M to 26.3��M. The results of anticancer evaluation revealed that all the screened derivatives possess mild anticancer potential. The in-silico ADME studies revealed that all the compounds were found to be drug-like. � 2022, The Author(s).